Physician
Choice Pain & Rehabilitation Center, LLC
Choice Pain & Rehabilitation Center, LLC was paid $11.10M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 56% of everything it billed.
33Billing provider infoCHOICE PAIN & REHABILITATION CENTER, LLC
LANHAM, MD 20706
LANHAM, MD 20706
33aNPI1568809598assigned 05/31/2013
33bProvider typeInterventional Pain Medicine Physician
28Total paid$11.10M
24GClaims191,842
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Interventional Pain Medicine Physician providers in Maryland
Rank by total paid#2 of 8
Median peer was paid$148K
This provider vs. median75×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,390 | $328K | |
| 2019 | 9,610 | $243K | |
| 2020 | 30,990 | $1.71M | |
| 2021 | 51,117 | $2.98M | |
| 2022 | 40,779 | $2.19M | |
| 2023 | 33,144 | $1.96M | |
| 2024incomplete | 20,812 | $1.69M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 56% | 85,106 | 68,239 | $6.18M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 15% | 26,648 | 19,412 | $1.62M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 10% | 38,914 | 29,214 | $1.13M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.9% | 18,519 | 15,368 | $993K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.6% | 3,377 | 2,984 | $404K |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | 1.7% | 574 | 402 | $194K |
| 93922 | 1.5% | 2,533 | 2,323 | $164K | |
| 95923 | 1.3% | 2,056 | 1,871 | $142K | |
| 95921 | <1% | 2,082 | 1,894 | $93K | |
| L1833 | Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf | <1% | 105 | 96 | $32K |
| 96138 | <1% | 1,557 | 1,259 | $25K | |
| 20610 | <1% | 671 | 446 | $21K |
40 more codes
| 96132 | <1% | 999 | $17K | |
| 64483 | <1% | 170 | $13K | |
| 99490 | Ccm add 20min | <1% | 1,120 | $12K |
| A4209 | Syringe with needle, sterile 5 cc or greater, each | <1% | 1,048 | $11K |
| J3490 | Unclassified drugs | <1% | 1,727 | $10K |
| 99457 | <1% | 385 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 51 | $6K |
| 97750 | <1% | 132 | $5K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 225 | $4K |
| 93923 | <1% | 86 | $4K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 41 | $3K |
| 20553 | <1% | 70 | $3K | |
| 99452 | <1% | 513 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 717 | $3K |
| 96130 | <1% | 238 | $2K | |
| 64493 | <1% | 20 | $2K | |
| 64494 | <1% | 17 | $599.76 | |
| 77003 | <1% | 179 | $461.56 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 201 | $310.64 |
| A4215 | Needle, sterile, any size, each | <1% | 821 | $264.16 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $113.40 |
| 99453 | <1% | 25 | $106.55 | |
| 99454 | <1% | 311 | $38.07 | |
| 80348 | 0% | 33 | $0.00 | |
| 80361 | 0% | 33 | $0.00 | |
| 80356 | 0% | 33 | $0.00 | |
| 80355 | 0% | 33 | $0.00 | |
| 80354 | 0% | 33 | $0.00 | |
| 80346 | 0% | 33 | $0.00 | |
| 80372 | 0% | 33 | $0.00 | |
| 80373 | 0% | 33 | $0.00 | |
| 80375 | 0% | 33 | $0.00 | |
| 80365 | 0% | 33 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 22 | $0.00 |
| 80359 | 0% | 33 | $0.00 | |
| 99458 | 0% | 35 | $0.00 | |
| 98977 | 0% | 53 | $0.00 | |
| 80358 | 0% | 33 | $0.00 | |
| 80349 | 0% | 33 | $0.00 | |
| 98980 | 0% | 52 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHOCKLEY, TRISTAN (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Choice Pain & Rehabilitation Center, LLC | Baltimore, MD | $3.69M |
| Choice Pain & Rehabilitation Center | Lanham, MD | $2.61M |
| Choice Pain & Rebabilitation Center LLC | Columbia, MD | $146K |
| Choice Pain & Rehabilitation Center, LLC | Rosedale, MD | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.